PharmaShots

MARCH 17, 2023

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40

FDA Labelling 40

pharmaphorum

JANUARY 5, 2022

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Hutchmed’s drug is also being paired with Tagrisso and AZ’s PD-L1 blocker Imfinzi (durvalumab) in global registrational trials.

FDA 111

FDA Chemotherapy 111

pharmaphorum

DECEMBER 23, 2021

Daiichi Sankyo has been granted breakthrough status by the FDA for patritumab deruxtecan, a HER3-targeted antibody-drug conjugate (ADC) in clinical trials for lung cancer. HER3 is expressed in more than 80% of EGFR-mutant NSCLC, and overexpression is associated with poor outcomes, but no HER3-targeted drugs have been approved to date.

FDA 72

FDA Chemotherapy 72

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments.

Labelling 52

Labelling Hospitals 52

The Checkup by Singlecare

SEPTEMBER 7, 2023

Fortunately, drug therapy for diabetes has come a long way. This class of diabetes drugs has been linked to decreasing appetite, and because of that, patients taking incretin mimetics can lead to weight loss. Some drugs in this class are FDA-approved to aid in weight loss and management.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

PharmD Live

JANUARY 25, 2022

Adverse drug events are avoided. A pharmacist who can review the additional added medications and ensure no adverse reactions are expected, and no drug interactions considerably lowers the risk to this population. Patient health improves, as do satisfaction scores and CMS reimbursements. Joseph Guglielmo, PharmD. Dean, Troy C.

Adverse Reactions 52

Adverse Reactions Patient Care Communication Hospitals 52

The Checkup by Singlecare

JANUARY 25, 2023

According to the Food and Drug Administration (FDA) , one popular misconception surrounding SPF relates to the time of solar exposure. However, more were familiar with the terms of broad-spectrum and water resistance in sunscreen products. More SPF means more UV radiation would be needed to burn skin, and a higher SPF is desirable.

Documentation 52

Documentation Insurance FDA 52

The Checkup by Singlecare

JUNE 21, 2023

The condition causes higher levels of androgen hormone production, resulting in symptoms such as irregular menstrual cycles, acne, excess hair growth, cysts, skin tags, thinning hair, skin darkening, and infertility. But she says that other GLP-1 RAs have more data to support their use as weight loss drugs.

Insurance 98

Insurance FDA Compounding Compounding Pharmacies 98

The Checkup by Singlecare

JANUARY 19, 2023

Insulin resistance and prediabetes Insulin is a hormone made by the pancreas that regulates blood sugar. People with insulin resistance do not respond well to insulin, so the pancreas makes more insulin. People with insulin resistance or prediabetes may not have any symptoms.

Immunization 105

Immunization Hospitals Communication 105